JPMorgan Chase & Co. Boosts MKS (NASDAQ:MKSI) Price Target to $305.00

MKS (NASDAQ:MKSI) had its price objective upped by research analysts at JPMorgan Chase & Co. from $265.00 to $305.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm currently has an “overweight” rating on the scientific and technical instruments company’s stock. JPMorgan Chase & Co.‘s price objective points to a potential upside of 23.20% from the company’s previous close.

Several other research firms also recently weighed in on MKSI. Deutsche Bank Aktiengesellschaft raised their price target on MKS from $265.00 to $305.00 and gave the stock a “buy” rating in a research report on Thursday. Mizuho set a $320.00 price objective on shares of MKS in a research note on Thursday. Needham & Company LLC raised their price objective on shares of MKS from $260.00 to $300.00 and gave the stock a “buy” rating in a report on Thursday. Benchmark increased their price target on shares of MKS from $135.00 to $180.00 and gave the stock a “buy” rating in a research report on Friday, November 7th. Finally, Cantor Fitzgerald boosted their price objective on MKS from $200.00 to $300.00 and gave the company an “overweight” rating in a report on Tuesday, January 20th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, MKS currently has a consensus rating of “Moderate Buy” and an average price target of $259.23.

MKS Price Performance

Shares of MKSI traded down $2.80 during trading hours on Thursday, reaching $247.57. The company had a trading volume of 319,823 shares, compared to its average volume of 1,652,383. The company has a current ratio of 2.86, a quick ratio of 1.81 and a debt-to-equity ratio of 1.64. The company has a market capitalization of $16.63 billion, a price-to-earnings ratio of 56.77, a PEG ratio of 1.83 and a beta of 1.95. MKS has a 12-month low of $54.84 and a 12-month high of $269.91. The firm has a 50 day simple moving average of $201.14 and a 200-day simple moving average of $154.11.

MKS (NASDAQ:MKSI) last released its quarterly earnings data on Tuesday, February 17th. The scientific and technical instruments company reported $2.47 EPS for the quarter, missing the consensus estimate of $2.51 by ($0.04). MKS had a return on equity of 21.30% and a net margin of 7.53%.The business had revenue of $1.03 billion during the quarter, compared to analysts’ expectations of $1.02 billion. During the same quarter in the prior year, the firm earned $2.15 earnings per share. MKS’s quarterly revenue was up 10.5% on a year-over-year basis. MKS has set its Q1 2026 guidance at 1.720-2.280 EPS. Research analysts expect that MKS will post 6.94 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director Elizabeth Mora sold 300 shares of the stock in a transaction that occurred on Tuesday, December 2nd. The shares were sold at an average price of $158.81, for a total value of $47,643.00. Following the completion of the sale, the director directly owned 18,963 shares of the company’s stock, valued at $3,011,514.03. This represents a 1.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.57% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in MKSI. Corient Private Wealth LLC boosted its holdings in shares of MKS by 2,170.2% during the 4th quarter. Corient Private Wealth LLC now owns 133,036 shares of the scientific and technical instruments company’s stock worth $21,259,000 after buying an additional 127,176 shares during the period. Mercer Global Advisors Inc. ADV increased its stake in shares of MKS by 48.0% in the fourth quarter. Mercer Global Advisors Inc. ADV now owns 10,968 shares of the scientific and technical instruments company’s stock valued at $1,753,000 after buying an additional 3,555 shares in the last quarter. EP Wealth Advisors LLC acquired a new position in MKS during the 4th quarter worth about $701,000. Mackenzie Financial Corp bought a new stake in MKS during the 4th quarter worth about $674,000. Finally, NewEdge Advisors LLC acquired a new stake in MKS in the 4th quarter valued at about $425,000. Institutional investors and hedge funds own 99.79% of the company’s stock.

More MKS News

Here are the key news stories impacting MKS this week:

• Positive Sentiment: Needham raised its price target to $300 and kept a Buy rating, citing the company’s secular exposure and strong end‑market positioning — this gives upside from current levels. Benzinga The Fly
• Positive Sentiment: MKS hit a new 52‑week high on the back of strong revenue growth and investor enthusiasm earlier in the week, signaling continued institutional interest. Article
• Positive Sentiment: The company completed a refinancing that improves its debt profile and raised the dividend — a shareholder‑friendly move that can support valuation over time. Yahoo Finance
• Neutral Sentiment: Q4 results: revenue grew ~10.5% to ~$1.03B and GAAP/non‑GAAP profits rose year‑over‑year, but non‑GAAP EPS of $2.47 missed consensus by a few cents. Overall operating performance mixed. MarketBeat
• Neutral Sentiment: Q1 2026 guidance: the company gave an EPS range of $1.72–$2.28 (vs. consensus ~ $1.88) and revenue roughly $1.04B ± $40M; management said guidance factors in current tariff uncertainty. Investors will focus on where guidance lands within that wide range. Seeking Alpha
• Negative Sentiment: Market reaction: shares pulled back after the print — traders cited the EPS miss, weaker operating cash flow and tariff/repricing caveats, plus a classic “sell‑the‑news” unwind from recent record highs. QuiverQuant
• Negative Sentiment: Analyst/market disappointment narrative: some coverage noted investors were looking for a larger beat and clearer margin/cash‑flow upside; media pieces highlighted the miss and called out potential margin headwinds from tariffs. MSN

About MKS

MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.